Furthermore, HO-1 positivity in chronic myeloid leukemia [169], acute myeloid leukemia [170], and myelodysplastic syndrome [171] correlate with disease progression, resistance to therapy, and relapse. This evidence concerns the gene HMOX1 and chronic myelogenous leukemia, BCR-ABL1 positive.